Biological Activity
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 12.74 mL | 63.7 mL | 127.4 mL |
0.5 mM | 2.55 mL | 12.74 mL | 25.48 mL |
1 mM | 1.27 mL | 6.37 mL | 12.74 mL |
5 mM | 0.25 mL | 1.27 mL | 2.55 mL |
*The above data is based on the productmolecular weight 784.92. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A15166 |
---|---|
Actions | Inhibitor |
M. Wt | 784.92 |
Formula | C38H52N6O10S |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1350462-55-3 |
Synonyms | MK5172 hydrate, MK 5172 hydrate |
SMILES | CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1.O |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy MK-5172 hydrate | MK-5172 hydrate Supplier | purchase | cost | manufacturer | order | distributor | buy 1350462-55-3| 1350462-55-3 Supplier | purchase 1350462-55-3 | 1350462-55-3 cost | 1350462-55-3 manufacturer | order 1350462-55-3 | 1350462-55-3 distributor